{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:07:54Z","timestamp":1778724474173,"version":"3.51.4"},"reference-count":55,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.3724\/abbs.2026085","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:50:54Z","timestamp":1778658654000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Neuronal PRRT3 coordinates amyloidogenic processing and                     Tau phosphorylation via distinct Ras-ERK-AP-1 and CaMKII\/PP2A pathways"],"prefix":"10.3724","author":[{"given":"Fei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaru","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xixiu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruitian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40035-025-00479-4","volume":"14","author":"Nam Y","year":"2025","unstructured":"Nam Y, Shin SJ, Kumar V, Won J, Kim S, Moon M. Dual modulation of amyloid beta and tau aggregation and                         dissociation in Alzheimer\u2019s disease: a comprehensive review of the                         characteristics and therapeutic strategies. Transl                             Neurodegener, 2025, 14: 15.","journal-title":"Transl                             Neurodegener"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"Vassar R","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB. \u03b2-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by                         the transmembrane aspartic protease BACE. Science, 1999, 286: 735-741.","journal-title":"Science"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/990114","volume":"402","author":"Sinha S","year":"1999","unstructured":"Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M. Purification and cloning of amyloid precursor protein \u03b2-secretase                         from human brain. Nature, 1999, 402: 537-540.","journal-title":"Nature"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/990107","volume":"402","author":"Yan R","year":"1999","unstructured":"Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashler JR. Membrane-anchored aspartyl protease with Alzheimer\u2019s disease                         \u03b2-secretase activity. Nature, 1999, 402: 533-537.","journal-title":"Nature"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/19077","volume":"398","author":"Wolfe MS","year":"1999","unstructured":"Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ. Two transmembrane aspartates in presenilin-1 required for                         presenilin endoproteolysis and \u03b3-secretase activity. Nature, 1999, 398: 513-517.","journal-title":"Nature"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/cells13151293","volume":"13","author":"Bagheri S","year":"2024","unstructured":"Bagheri S, Saboury AA, Saso L. Sequence of molecular events in the development of Alzheimer\u2019s                         disease: cascade interactions from beta-amyloid to other involved proteins. Cells, 2024, 13: 1293.","journal-title":"Cells"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Chen Y","year":"2023","unstructured":"Chen Y, Yu Y. Tau and neuroinflammation in Alzheimer\u2019s disease: interplay                         mechanisms and clinical translation. J Neuroinflamm, 2023, 20: 165.","journal-title":"J Neuroinflamm"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"102639","DOI":"10.1016\/j.arr.2024.102639","volume":"104","author":"Singh S","year":"2025","unstructured":"Singh S, Khan S, Shahid M, Sardar M, Hassan MI, Islam A. Targeting tau in Alzheimer\u2019s and beyond: insights into pathology                         and therapeutic strategies. Ageing Res Rev, 2025, 104: 102639.","journal-title":"Ageing Res Rev"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.conb.2021.03.003","volume":"69","author":"Wegmann S","year":"2021","unstructured":"Wegmann S, Biernat J, Mandelkow E. A current view on tau protein phosphorylation in Alzheimer\u2019s                         disease. Curr Opin                             Neurobiol, 2021, 69: 131-138.","journal-title":"Curr Opin                             Neurobiol"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/ijms232112841","volume":"23","author":"Rawat P","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH. Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci, 2022, 23: 12841.","journal-title":"Int J Mol Sci"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2009.08.036","volume":"64","author":"Zhang Y","year":"2009","unstructured":"Zhang Y, Liu S, Zhang X, Li WB, Chen Y, Huang X, Sun L. A functional mouse retroposed gene Rps23r1 reduces Alzheimer\u2019s                         \u03b2-amyloid levels and tau phosphorylation. Neuron, 2009, 64: 328-340.","journal-title":"Neuron"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1326-8-16","volume":"8","author":"Liraz O","year":"2013","unstructured":"Liraz O, Boehm-Cagan A, Michaelson DM. ApoE4 induces A\u03b242, tau, and neuronal pathology in the                         hippocampus of young targeted replacement apoE4 mice. Mol                             Neurodegeneration, 2013, 8: 16.","journal-title":"Mol                             Neurodegeneration"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/alzrt265","volume":"6","author":"Kitagishi Y","year":"2014","unstructured":"Kitagishi Y, Nakanishi A, Ogura Y, Matsuda S. Dietary regulation of PI3K\/AKT\/GSK-3\u03b2 pathway in Alzheimer\u2019s                         disease. AlzheimersRes Ther, 2014, 6: 35.","journal-title":"AlzheimersRes Ther"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mds.27274","volume":"33","author":"Tian W","year":"2018","unstructured":"Tian W, Huang X, Mao X, Liu Q, Liu X, Zeng S, Guo X. Proline-rich transmembrane protein 2-negative paroxysmal                         kinesigenic dyskinesia: clinical and genetic analyses of 163 patients. Movement Disord, 2018, 33: 459-467.","journal-title":"Movement Disord"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/cr.2017.128","volume":"28","author":"Tan GH","year":"2018","unstructured":"Tan GH, Liu YY, Wang L, Li K, Zhang ZQ, Li HF, Yang ZF. PRRT2 deficiency induces paroxysmal kinesigenic dyskinesia by                         regulating synaptic transmission in cerebellum. Cell Res, 2018, 28: 90-110.","journal-title":"Cell Res"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cr.2017.142","volume":"28","author":"Kros L","year":"2018","unstructured":"Kros L, De Zeeuw CI. PRRT2-dependent dyskinesia: cerebellar, parox-ysmal and                         persistent. Cell Res, 2018, 28: 3-4.","journal-title":"Cell Res"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.celrep.2016.03.005","volume":"15","author":"Valente P","year":"2016","unstructured":"Valente P, Castroflorio E, Rossi P, Fadda M, Sterlini B, Cervigni RI, Prestigio C. PRRT2 is a key component of the Ca2+-dependent neurotransmitter                         release machinery. Cell Rep, 2016, 15: 117-131.","journal-title":"Cell Rep"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.3390\/ijms22094914","volume":"22","author":"Cascella R","year":"2021","unstructured":"Cascella R, Cecchi C. Calcium dyshomeostasis in Alzheimer\u2019s disease pathogenesis. Int J Mol Sci, 2021, 22: 4914.","journal-title":"Int J Mol Sci"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"Uhl\u00e9n M","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson \u00c5. Tissue-based map of the human proteome. Science, 2015, 347: 1260419.","journal-title":"Science"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"eaay5947","DOI":"10.1126\/science.aay5947","volume":"367","author":"Sj\u00f6stedt E","year":"2020","unstructured":"Sj\u00f6stedt E, Zhong W, Fagerberg L, Karlsson M, Mitsios N, Adori C, Oksvold P. An atlas of the protein-coding genes in the human, pig, and mouse                         brain. Science, 2020, 367: eaay5947.","journal-title":"Science"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"Aguet F","year":"2020","unstructured":"Aguet F, Anand S, Ardlie KG, Gabriel S, Getz GA, Graubert A, Hadley K. The GTEx consortium atlas of genetic regulatory effects across                         human tissues. Science, 2020, 369: 1318-1330.","journal-title":"Science"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"Edgar R","year":"2002","unstructured":"Edgar R. Gene expression omnibus: NCBI gene expression and hybridization                         array data repository. Nucleic Acids Res, 2002, 30: 207-210.","journal-title":"Nucleic Acids Res"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"Johnson WE","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using                         empirical Bayes methods. Biostatistics, 2007, 8: 118-127.","journal-title":"Biostatistics"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"Leek JT","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted                         variation in high-throughput experiments. Bioinformatics, 2012, 28: 882-883.","journal-title":"Bioinformatics"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"39907","DOI":"10.1074\/jbc.M606015200","volume":"281","author":"Pierrot N","year":"2006","unstructured":"Pierrot N, Santos SF, Feyt C, Morel M, Brion JP, Octave JN. Calcium-mediated transient phosphorylation of tau and amyloid                         precursor protein followed by intraneuronal amyloid-\u03b2 accumulation. J Biol Chem, 2006, 281: 39907-39914.","journal-title":"J Biol Chem"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"844","DOI":"10.2174\/156720512802455322","volume":"9","author":"I. Mota S","year":"2012","unstructured":"I. Mota S, L. Ferreira I, Pereira C, R. Oliveira C, Cristina Rego A. Amyloid-beta peptide 1\u201342 causes microtubule deregulation through                         N-methyl-D-aspartate receptors in mature hippocampal cultures. Curr Alzheimer                             Res, 2012, 9: 844-856.","journal-title":"Curr Alzheimer                             Res"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ceca.2011.11.008","volume":"51","author":"Ferreira IL","year":"2012","unstructured":"Ferreira IL, Bajouco LM, Mota SI, Auberson YP, Oliveira CR, Rego AC. Amyloid beta peptide 1\u201342 disturbs intracellular calcium                         homeostasis through activation of GluN2B-containing N-methyl-D-aspartate                         receptors in cortical cultures. Cell Calcium, 2012, 51: 95-106.","journal-title":"Cell Calcium"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"18727","DOI":"10.1073\/pnas.0606298103","volume":"103","author":"Sun X","year":"2006","unstructured":"Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, Staufenbiel M. Hypoxia facilitates Alzheimer\u2019s disease pathogenesis by                         up-regulating BACE1 gene expression. Proc Natl Acad Sci                             USA, 2006, 103: 18727-18732.","journal-title":"Proc Natl Acad Sci                             USA"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1128\/MCB.24.2.865-874.2004","volume":"24","author":"Christensen MA","year":"2004","unstructured":"Christensen MA, Zhou W, Qing H, Lehman A, Philipsen S, Song W. Transcriptional regulation of BACE1, the \u03b2-amyloid precursor                         protein \u03b2-secretase, by Sp1. Mol Cell                             Biol, 2004, 24: 865-874.","journal-title":"Mol Cell                             Biol"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"7285","DOI":"10.1073\/pnas.1507125112","volume":"112","author":"Darmanis S","year":"2015","unstructured":"Darmanis S, Sloan SA, Zhang Y, Enge M, Caneda C, Shuer LM, Hayden Gephart MG. A survey of human brain transcriptome diversity at the single                         cell level. Proc Natl Acad Sci                             USA, 2015, 112: 7285-7290.","journal-title":"Proc Natl Acad Sci                             USA"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","volume":"168","author":"Huang YWA","year":"2017","unstructured":"Huang YWA, Zhou B, Wernig M, S\u00fcdhof TC. ApoE2, ApoE3, and apoe4 differentially stimulate APP                         transcription and A\u03b2 secretion. Cell, 2017, 168: 427-441.e21.","journal-title":"Cell"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1756-6606-6-44","volume":"6","author":"Chen XF","year":"2013","unstructured":"Chen XF, Zhang Y, Xu H, Bu G. Transcriptional regulation and its misregulation in Alzheimer\u2019s                         disease. Mol Brain, 2013, 6: 44.","journal-title":"Mol Brain"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"Love MI","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq                         data with DESeq2. Genome Biol, 2014, 15: 550.","journal-title":"Genome Biol"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"Kanehisa M","year":"2000","unstructured":"Kanehisa M. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res, 2000, 28: 27-30.","journal-title":"Nucleic Acids Res"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"Subramanian A","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A. Gene set enrichment analysis: a knowledge-based approach for                         interpreting genome-wide expression profiles. Proc Natl Acad Sci                             USA, 2005, 102: 15545-15550.","journal-title":"Proc Natl Acad Sci                             USA"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2147\/NDT.S350939","volume":"Volume 18","author":"Ge M","year":"2022","unstructured":"Ge M, Zhang J, Chen S, Huang Y, Chen W, He L, Zhang Y. Role of calcium homeostasis in Alzheimer\u2019s disease. Neuropsychiatr Dis                             Treat, 2022, Volume 18: 487-498.","journal-title":"Neuropsychiatr Dis                             Treat"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"e15984","DOI":"10.15252\/emmm.202215984","volume":"15","author":"Indrigo M","year":"2023","unstructured":"Indrigo M, Morella I, Orellana D, d\u2032Isa R, Papale A, Parra R, Gurgone A. Nuclear ERK1\/2 signaling potentiation enhances neuroprotection                         and cognition via importin\u03b11\/KPNA2. EMBO Mol Med, 2023, 15: e15984.","journal-title":"EMBO Mol Med"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fnmol.2014.00016","volume":"7","author":"Sontag JM","year":"2014","unstructured":"Sontag JM, Sontag E. Protein phosphatase 2A dysfunction in Alzheimer's disease. Front Mol                             Neurosci, 2014, 7: 16.","journal-title":"Front Mol                             Neurosci"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","volume":"20","author":"Thijssen EH","year":"2021","unstructured":"Thijssen EH, La Joie R, Strom A, Fonseca C, Iaccarino L, Wolf A, Spina S. Plasma phosphorylated tau 217 and phosphorylated tau 181 as                         biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a                         retrospective diagnostic performance study. Lancet                             Neurol, 2021, 20: 739-752.","journal-title":"Lancet                             Neurol"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","volume":"141","author":"Ashton NJ","year":"2021","unstructured":"Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G, Snellman A. Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s                         disease pathology. Acta                             Neuropathol, 2021, 141: 709-724.","journal-title":"Acta                             Neuropathol"},{"key":"CITATION41","unstructured":"Jin H, Hu Z, Dong M, Wu Y, Zhu Z, Xu L. Ketamine induces Tau                         hyperphosphorylation at serine 404 in the hippocampus of neonatal rats.                              Neural Regen Res                          2013, 8:                         1590\u20131596."},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40478-018-0557-6","volume":"6","author":"Neddens J","year":"2018","unstructured":"Neddens J, Temmel M, Flunkert S, Kerschbaumer B, Hoeller C, Loeffler T, Niederkofler V. Phosphorylation of different tau sites during progression of                         Alzheimer\u2019s disease. Acta Neuropathol                             Commun, 2018, 6: 52.","journal-title":"Acta Neuropathol                             Commun"},{"key":"CITATION43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1604519113","volume":"113","author":"Yin Y","year":"2016","unstructured":"Yin Y, Gao D, Wang Y, Wang ZH, Wang X, Ye J, Wu D. Tau accumulation induces synaptic impairment and memory deficit                         by calcineurin-mediated inactivation of nuclear CaMKIV\/CREB signaling. Proc Natl Acad Sci                             USA, 2016, 113.","journal-title":"Proc Natl Acad Sci                             USA"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13041-015-0166-2","volume":"8","author":"Ghosh A","year":"2015","unstructured":"Ghosh A, Giese KP. Calcium\/calmodulin-dependent kinase II and Alzheimer\u2019s disease. Mol Brain, 2015, 8: 78.","journal-title":"Mol Brain"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"16482","DOI":"10.1523\/JNEUROSCI.3418-14.2014","volume":"34","author":"Warmus BA","year":"2014","unstructured":"Warmus BA, Sekar DR, McCutchen E, Schellenberg GD, Roberts RC, McMahon LL, Roberson ED. Tau-mediated NMDA receptor impairment underlies dysfunction of a                         selectively vulnerable network in a mouse model of frontotemporal dementia. J Neurosci, 2014, 34: 16482-16495.","journal-title":"J Neurosci"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3389\/fnins.2017.00626","volume":"11","author":"Avila J","year":"2017","unstructured":"Avila J, Llorens-Mart\u00edn M, Pallas-Bazarra N, Bol\u00f3s M, Perea JR, Rodr\u00edguez-Matell\u00e1n A, Hern\u00e1ndez F. Cognitive decline in neuronal aging and Alzheimer\u2019s disease: role                         of NMDA receptors and associated proteins. Front Neurosci, 2017, 11: 626.","journal-title":"Front Neurosci"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.3233\/JAD-2012-129025","volume":"33","author":"Hernandez F","year":"2012","unstructured":"Hernandez F, Lucas JJ, Avila J, Perry G, Zhu X, Smith MA, Sorensen A. GSK3 and tau: two convergence points in Alzheimer\u2019s disease. J Alzheimer Dis, 2012, 33: S141-S144.","journal-title":"J Alzheimer Dis"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","volume":"12","author":"Martin L","year":"2013","unstructured":"Martin L, Latypova X, Wilson CM, Magnaudeix A, Perrin ML, Yardin C, Terro F. Tau protein kinases: involvement in Alzheimer\u2019s disease. Ageing Res Rev, 2013, 12: 289-309.","journal-title":"Ageing Res Rev"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1096\/fasebj.14.2.231","volume":"14","author":"Kay BK","year":"2000","unstructured":"Kay BK, Williamson MP, Sudol M. The importance of being proline: the interaction of proline-rich                         motifs in signaling proteins with their cognate domains. FASEB Journal, 2000, 14: 231-241.","journal-title":"FASEB Journal"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41419-021-03569-z","volume":"12","author":"Sterlini B","year":"2021","unstructured":"Sterlini B, Romei A, Parodi C, Aprile D, Oneto M, Aperia A, Valente P. An interaction between PRRT2 and Na+\/K+ ATPase contributes to the                         control of neuronal excitability. Cell Death Dis, 2021, 12: 292.","journal-title":"Cell Death Dis"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","volume":"60","author":"Small SA","year":"2008","unstructured":"Small SA, Duff K. Linking A\u03b2 and tau in late-onset Alzheimer\u2019s disease: a dual                         pathway hypothesis. Neuron, 2008, 60: 534-542.","journal-title":"Neuron"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"van Dyck CH","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med, 2023, 388: 9-21.","journal-title":"N Engl J Med"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"Sims JR","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks JD, Wessels AM. Donanemab in early symptomatic Alzheimer disease. JAMA, 2023, 330: 512-527.","journal-title":"JAMA"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev-neuro-070918-050501","volume":"42","author":"Bennett CF","year":"2019","unstructured":"Bennett CF, Krainer AR, Cleveland DW. Antisense oligonucleotide therapies for neurodegenerative                         diseases. Annu                             Rev Neurosci, 2019, 42: 385-406.","journal-title":"Annu                             Rev Neurosci"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"Finkel RS","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, Chiriboga CA. Nusinersen versus sham control in infantile-onset spinal muscular                         atrophy. N Engl J Med, 2017, 377: 1723-1732.","journal-title":"N Engl J Med"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/12DE4A6B11AE4F24838A69C2AB1EAC58","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026085","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/12DE4A6B11AE4F24838A69C2AB1EAC58","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:17:10Z","timestamp":1778721430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":55,"URL":"https:\/\/doi.org\/10.3724\/abbs.2026085","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}